A new study indicates a benefit for all young colon cancer patients to have genetic testing. But with more than half exhibiting no family history, will insurers cover the tests?

Personalized dosing of omega-3 fatty acids decreases prostaglandin E2 in the colon, but the beneficial effects are smaller in overweight people, research finds.

Fusobacterium nucleatum promotes resistance to chemotherapy in colon cancer patients by turning off the push button for cancer cell suicide, a new study finds.

High-quality imaging, surgical expertise and ongoing research will help specialists treat the complexities of rectal cancer while preserving patients’ quality of life.

A multidisciplinary treatment approach to colorectal liver metastases has changed the treatment landscape for patients.

After a colorectal cancer patient finishes treatment, primary care doctors take the reins and keep tabs. New guidelines are aiding the transition.